306 related articles for article (PubMed ID: 30632789)
1. Effects of MDR1 (C3435T) Polymorphism on Resistance, Uptake, and Efflux to Antiepileptic Drugs.
Shen XM; Cheng J
DNA Cell Biol; 2019 Mar; 38(3):250-255. PubMed ID: 30632789
[TBL] [Abstract][Full Text] [Related]
2. Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus.
Wang R; Sun X; Deng YS; Qiu XW
Xenobiotica; 2019 Nov; 49(11):1373-1378. PubMed ID: 30587068
[TBL] [Abstract][Full Text] [Related]
3. Influence of ABCB1 (1236C > T, 2677G > T and 3435C > T) polymorphisms on the transport ability of P-gp-mediated sunitinib in Caco-2 cell line.
Tan DQ
Xenobiotica; 2020 Mar; 50(3):346-353. PubMed ID: 31023123
[TBL] [Abstract][Full Text] [Related]
4. The drug-transporter gene MDR1 C3435T and G2677T/A polymorphisms and the risk of multidrug-resistant epilepsy in Turkish children.
Seven M; Batar B; Unal S; Yesil G; Yuksel A; Guven M
Mol Biol Rep; 2014 Jan; 41(1):331-6. PubMed ID: 24213830
[TBL] [Abstract][Full Text] [Related]
5.
Gao YL; He B
DNA Cell Biol; 2018 Dec; 37(12):1055-1060. PubMed ID: 30256659
[TBL] [Abstract][Full Text] [Related]
6.
Jiang B; Yan LJ; Wu Q
DNA Cell Biol; 2019 May; 38(5):485-490. PubMed ID: 30977678
[TBL] [Abstract][Full Text] [Related]
7. A multi-system approach assessing the interaction of anticonvulsants with P-gp.
Dickens D; Yusof SR; Abbott NJ; Weksler B; Romero IA; Couraud PO; Alfirevic A; Pirmohamed M; Owen A
PLoS One; 2013; 8(5):e64854. PubMed ID: 23741405
[TBL] [Abstract][Full Text] [Related]
8. MDR1 (ABCB1) G1199A (Ser400Asn) polymorphism alters transepithelial permeability and sensitivity to anticancer agents.
Woodahl EL; Crouthamel MH; Bui T; Shen DD; Ho RJ
Cancer Chemother Pharmacol; 2009 Jun; 64(1):183-8. PubMed ID: 19123050
[TBL] [Abstract][Full Text] [Related]
9. Flavonoid compounds as reversing agents of the P-glycoprotein-mediated multidrug resistance: An in vitro evaluation with focus on antiepileptic drugs.
Ferreira A; Rodrigues M; Fortuna A; Falcão A; Alves G
Food Res Int; 2018 Jan; 103():110-120. PubMed ID: 29389596
[TBL] [Abstract][Full Text] [Related]
10. MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia.
Jamroziak K; Balcerczak E; Smolewski P; Robey RW; Cebula B; Panczyk M; Kowalczyk M; Szmigielska-Kapłon A; Mirowski M; Bates SE; Robak T
Pharmacol Rep; 2006; 58(5):720-8. PubMed ID: 17085864
[TBL] [Abstract][Full Text] [Related]
11. Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport.
Kuteykin-Teplyakov K; Luna-Tortós C; Ambroziak K; Löscher W
Br J Pharmacol; 2010 Jul; 160(6):1453-63. PubMed ID: 20590635
[TBL] [Abstract][Full Text] [Related]
12. MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer.
Fung KL; Pan J; Ohnuma S; Lund PE; Pixley JN; Kimchi-Sarfaty C; Ambudkar SV; Gottesman MM
Cancer Res; 2014 Jan; 74(2):598-608. PubMed ID: 24305879
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Endogenous Breast Cancer Resistance Protein on Human P-Glycoprotein-Mediated Transport Assays Using LLC-PK1 Cells Transfected With Human P-Glycoprotein.
Miyamoto R; Nozawa T; Shiozuka K; Tabata K
J Pharm Sci; 2019 Mar; 108(3):1085-1089. PubMed ID: 30339864
[TBL] [Abstract][Full Text] [Related]
14. Is aspirin a substrate of MDR1/P-glycoprotein?
Singh R; Naik T; Nigam A; Chatterjee S; Rajanna P; Shen H; Iyer R
Xenobiotica; 2020 Oct; 50(10):1258-1264. PubMed ID: 32302241
[TBL] [Abstract][Full Text] [Related]
15. Impacts of ABCB1 (G1199A) polymorphism on resistance, uptake, and efflux to steroid drugs.
Peng R; Zhang H; Zhang Y; Wei DY
Xenobiotica; 2016 Oct; 46(10):948-52. PubMed ID: 26822676
[TBL] [Abstract][Full Text] [Related]
16. Interactions of attention-deficit/hyperactivity disorder therapeutic agents with the efflux transporter P-glycoprotein.
Zhu HJ; Wang JS; Donovan JL; Jiang Y; Gibson BB; DeVane CL; Markowitz JS
Eur J Pharmacol; 2008 Jan; 578(2-3):148-58. PubMed ID: 17963743
[TBL] [Abstract][Full Text] [Related]
17. [The effect of MDR1 gene polymorphism in the pathogenesis and the treatment of drug-resistant epilepsy].
Białecka M; Hnatyszyn G; Bielicka-Cymerman J; Droździk M
Neurol Neurochir Pol; 2005; 39(6):476-81. PubMed ID: 16355305
[TBL] [Abstract][Full Text] [Related]
18. Association between C3435T polymorphism of MDR1 gene and the incidence of drug-resistant epilepsy in the population of Polish children.
Stasiołek M; Romanowicz H; Połatyńska K; Chamielec M; Skalski D; Makowska M; Smolarz B
Behav Brain Funct; 2016 Jul; 12(1):21. PubMed ID: 27391700
[TBL] [Abstract][Full Text] [Related]
19. Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans.
Giessmann T; May K; Modess C; Wegner D; Hecker U; Zschiesche M; Dazert P; Grube M; Schroeder E; Warzok R; Cascorbi I; Kroemer HK; Siegmund W
Clin Pharmacol Ther; 2004 Sep; 76(3):192-200. PubMed ID: 15371980
[TBL] [Abstract][Full Text] [Related]
20. Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines.
van der Sandt IC; Blom-Roosemalen MC; de Boer AG; Breimer DD
Eur J Pharm Sci; 2000 Sep; 11(3):207-14. PubMed ID: 11042226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
